• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Asherman 综合征:这可能并不全是我们的错。

Asherman's Syndrome: it may not be all our fault.

机构信息

Igenomix Academy, Valencia, Spain.

IVI Barcelonaii.

出版信息

Hum Reprod. 2018 Aug 1;33(8):1374-1380. doi: 10.1093/humrep/dey232.

DOI:10.1093/humrep/dey232
PMID:31986212
Abstract

Asherman's Syndrome (AS) is an acquired condition defined by the presence of intrauterine adhesions (IUA) that cause symptoms such as menstrual abnormalities, pelvic pain, infertility, recurrent miscarriage, abnormal placentation and attendant psychological distress. Classically, AS is considered an iatrogenic disease triggered by trauma to the pregnant uterus. Different factors can cause the destruction of the endometrium, thus affecting the endometrial stem cell niche and creating IUAs. Curettage of the pregnant uterus appears to be the most common source of this destruction. Nevertheless, some AS cases have been associated with congenital uterine abnormalities and infections, and there are some idiopathic cases without any prior surgical procedures, suggesting a putative constitutional predisposition to IUA. Factors reported to cause AS share an underlying inflammatory mechanism leading to defective endometrial healing and vascularization. Interestingly, distinct genetic profiles have been observed in the endometrium of AS patients. These data suggest that AS might not just be an iatrogenic complication, but also the result of a genetic predisposition. Elucidating the possible physiopathological processes that contribute to AS will help to identify patients at risk for this condition, providing an opportunity for prevention.

摘要

Asherman 综合征(AS)是一种后天获得性疾病,其特征为宫腔粘连(IUA)引起的月经异常、盆腔痛、不孕、复发性流产、胎盘异常和相关的心理困扰等症状。经典的 AS 被认为是一种医源性疾病,由妊娠子宫创伤引发。多种因素可导致子宫内膜破坏,从而影响子宫内膜干细胞龛,形成 IUA。刮宫术似乎是导致这种破坏的最常见原因。然而,一些 AS 病例与先天性子宫异常和感染有关,还有一些特发性病例没有任何先前的手术,这表明可能存在对 IUA 的先天倾向。据报道,导致 AS 的因素具有潜在的炎症机制,导致子宫内膜愈合和血管生成缺陷。有趣的是,AS 患者的子宫内膜观察到了不同的基因谱。这些数据表明,AS 可能不仅仅是一种医源性并发症,也是遗传易感性的结果。阐明可能导致 AS 的病理生理过程将有助于识别有这种疾病风险的患者,为预防提供机会。

相似文献

1
Asherman's Syndrome: it may not be all our fault.Asherman 综合征:这可能并不全是我们的错。
Hum Reprod. 2018 Aug 1;33(8):1374-1380. doi: 10.1093/humrep/dey232.
2
Avoiding Asherman's syndrome: refining our approach to uterine evacuation.避免阿谢曼综合征:优化我们的子宫排空方法。
Fertil Steril. 2021 Oct;116(4):961-962. doi: 10.1016/j.fertnstert.2021.06.037. Epub 2021 Jul 28.
3
Endometrial Regeneration in Asherman's Syndrome: Clinical and Translational evidence of Stem Cell Therapies.Asherman 综合征中的子宫内膜再生:干细胞疗法的临床和转化证据。
Curr Stem Cell Res Ther. 2019;14(6):454-459. doi: 10.2174/1574888X14666190213100528.
4
[Intrauterine adhesions--Asherman's syndrome].[宫腔粘连——阿什曼综合征]
Duodecim. 2010;126(21):2486-91.
5
Curettage and Asherman's syndrome-lessons to (re-) learn?刮宫术与阿谢曼综合征——需要(重新)吸取的教训?
J Obstet Gynaecol Can. 2014 Nov;36(11):997-1001. doi: 10.1016/S1701-2163(15)30413-8.
6
A matched cohort study comparing the outcome of intrauterine adhesiolysis for Asherman's syndrome after uterine artery embolization or surgical trauma.一项配对队列研究,比较子宫动脉栓塞或手术创伤后宫腔粘连松解术治疗阿谢曼综合征的效果。
J Minim Invasive Gynecol. 2014 Nov-Dec;21(6):1022-8. doi: 10.1016/j.jmig.2014.04.015. Epub 2014 May 16.
7
[Asherman's syndrome I--history, prevalence, histopathology, classification, ethiology, symtomatology and investigations].[阿谢曼综合征I——历史、患病率、组织病理学、分类、病因、症状学及检查]
Ceska Gynekol. 2010 Dec;75(6):492-8.
8
Classification systems of Asherman's syndrome. An old problem with new directions.Asherman 综合征的分类系统。一个老问题,新方向。
Minim Invasive Ther Allied Technol. 2021 Oct;30(5):304-310. doi: 10.1080/13645706.2021.1893190. Epub 2021 Mar 4.
9
Hysteroscopic Management of Asherman's Syndrome.宫腔镜在 Asherman 综合征中的处理。
J Minim Invasive Gynecol. 2018 Feb;25(2):218-228. doi: 10.1016/j.jmig.2017.09.020. Epub 2017 Oct 9.
10
Asherman's syndrome.Asherman 综合征。
Semin Reprod Med. 2011 Mar;29(2):83-94. doi: 10.1055/s-0031-1272470. Epub 2011 Mar 24.

引用本文的文献

1
The effectiveness of stem cell‑derived extracellular vesicles therapy for intrauterine adhesions: a meta-analysis of preclinical studies.干细胞衍生的细胞外囊泡疗法治疗宫腔粘连的有效性:一项临床前研究的荟萃分析。
Reprod Biol Endocrinol. 2025 Aug 13;23(1):117. doi: 10.1186/s12958-025-01448-2.
2
Single-cell sequencing uncovers disrupted stromal-macrophage communication as a driver of intrauterine adhesion progression.单细胞测序揭示了基质-巨噬细胞通讯中断是宫腔粘连进展的驱动因素。
Commun Biol. 2025 Aug 11;8(1):1194. doi: 10.1038/s42003-025-08634-3.
3
Enhancing exosome stability and delivery with natural polymers to prevent intrauterine adhesions and promote endometrial regeneration: a review.
利用天然聚合物增强外泌体稳定性和递送以预防宫腔粘连并促进子宫内膜再生:综述
J Nanobiotechnology. 2025 Jul 21;23(1):529. doi: 10.1186/s12951-025-03603-8.
4
Retrospective Analysis of Prognostic Factors and Pregnancy Outcomes in Patients with Moderate-to-Severe Intrauterine Adhesions Following Hysteroscopic Adhesiolysis and Modified Intrauterine Stent Intervention.宫腔镜粘连松解术联合改良宫腔支架置入术后中重度宫腔粘连患者预后因素及妊娠结局的回顾性分析
Ther Clin Risk Manag. 2025 Jun 21;21:929-939. doi: 10.2147/TCRM.S511425. eCollection 2025.
5
Identification and Validation of RPL7 and RCCD1 as Potential Biomarkers Associated with Immune Infiltration in Patients with Thin Endometrium.RPL7和RCCD1作为薄子宫内膜患者免疫浸润相关潜在生物标志物的鉴定与验证
Reprod Sci. 2025 Jun 2. doi: 10.1007/s43032-025-01883-x.
6
Umbilical cord-derived mesenchymal stem cells combined with kaempferol synergistically promote repair of damaged endometrium by modulating JAK2/STAT3 signaling pathway.脐带间充质干细胞与山奈酚联合通过调节JAK2/STAT3信号通路协同促进受损子宫内膜的修复。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 23. doi: 10.1007/s00210-025-04056-4.
7
Novel therapeutic strategies for Asherman's syndrome: Endometrial regeneration using menstrual blood-derived stem cells.阿谢曼综合征的新型治疗策略:使用月经血源性干细胞进行子宫内膜再生。
Regen Ther. 2025 Apr 5;29:328-340. doi: 10.1016/j.reth.2025.03.019. eCollection 2025 Jun.
8
Development of regenerative therapies targeting fibrotic endometrium in intrauterine adhesion or thin endometrium to restore uterine function.开发针对宫腔粘连或薄型子宫内膜中纤维化子宫内膜的再生疗法,以恢复子宫功能。
Sci China Life Sci. 2025 Apr 11. doi: 10.1007/s11427-024-2842-6.
9
Enhanced myofibroblast differentiation of eMSCs in intrauterine adhesions.子宫粘连中子宫内膜间充质干细胞的肌成纤维细胞分化增强。
Stem Cell Res Ther. 2025 Feb 4;16(1):35. doi: 10.1186/s13287-025-04183-y.
10
Long-term therapeutic effects of allogeneic mesenchymal stem cell transplantation for intrauterine adhesions.同种异体间充质干细胞移植治疗宫腔粘连的长期疗效
Stem Cell Res Ther. 2024 Dec 23;15(1):499. doi: 10.1186/s13287-024-04100-9.